BR9606409A - Composto opticamente ativo composição farmacêutica processos para inibir agregação de plaqueta em um animal de sangue quente ligação de fibrinogênio a gpiib/iia em um animal de sangue quente e eventos trombóticos que acompanham agnina instável em animal de sangue quente e uso do composto opticamante ativo - Google Patents
Composto opticamente ativo composição farmacêutica processos para inibir agregação de plaqueta em um animal de sangue quente ligação de fibrinogênio a gpiib/iia em um animal de sangue quente e eventos trombóticos que acompanham agnina instável em animal de sangue quente e uso do composto opticamante ativoInfo
- Publication number
- BR9606409A BR9606409A BR9606409A BR9606409A BR9606409A BR 9606409 A BR9606409 A BR 9606409A BR 9606409 A BR9606409 A BR 9606409A BR 9606409 A BR9606409 A BR 9606409A BR 9606409 A BR9606409 A BR 9606409A
- Authority
- BR
- Brazil
- Prior art keywords
- warm
- active compound
- optically active
- blooded animal
- blooded
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title 3
- 150000001875 compounds Chemical class 0.000 title 2
- 102000008946 Fibrinogen Human genes 0.000 title 1
- 108010049003 Fibrinogen Proteins 0.000 title 1
- 208000007536 Thrombosis Diseases 0.000 title 1
- 229940012952 fibrinogen Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/457,538 US5652242A (en) | 1993-03-29 | 1995-06-01 | Heterocyclic derivatives |
| GBGB9518188.9A GB9518188D0 (en) | 1995-09-07 | 1995-09-07 | Optically active derivative |
| PCT/GB1996/001260 WO1996038416A1 (en) | 1995-06-01 | 1996-05-28 | (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR9606409A true BR9606409A (pt) | 1997-09-30 |
Family
ID=26307696
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR9606409A BR9606409A (pt) | 1995-06-01 | 1996-05-28 | Composto opticamente ativo composição farmacêutica processos para inibir agregação de plaqueta em um animal de sangue quente ligação de fibrinogênio a gpiib/iia em um animal de sangue quente e eventos trombóticos que acompanham agnina instável em animal de sangue quente e uso do composto opticamante ativo |
Country Status (31)
| Country | Link |
|---|---|
| EP (1) | EP0796247A1 (sv) |
| JP (1) | JP2885941B2 (sv) |
| KR (1) | KR100245957B1 (sv) |
| AT (1) | AT406675B (sv) |
| AU (1) | AU710105B2 (sv) |
| BE (1) | BE1009520A5 (sv) |
| BR (1) | BR9606409A (sv) |
| CA (1) | CA2194397A1 (sv) |
| CH (1) | CH691808A5 (sv) |
| CZ (1) | CZ26997A3 (sv) |
| DE (1) | DE19680509T1 (sv) |
| DK (1) | DK10697A (sv) |
| ES (1) | ES2137886B1 (sv) |
| FI (1) | FI970393L (sv) |
| GB (1) | GB2304340B (sv) |
| GR (1) | GR1002702B (sv) |
| HU (1) | HUP9700274A3 (sv) |
| IE (1) | IE960405A1 (sv) |
| IL (1) | IL118477A0 (sv) |
| IT (1) | IT1290839B1 (sv) |
| LU (1) | LU90008B1 (sv) |
| MC (1) | MC2418A1 (sv) |
| MX (1) | MX9700379A (sv) |
| NL (1) | NL1003243C2 (sv) |
| NO (1) | NO307460B1 (sv) |
| NZ (1) | NZ308597A (sv) |
| PL (1) | PL318440A1 (sv) |
| SE (1) | SE510812C2 (sv) |
| SK (1) | SK13097A3 (sv) |
| TR (1) | TR199700020T1 (sv) |
| WO (1) | WO1996038416A1 (sv) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0100158A3 (en) * | 1982-07-28 | 1985-03-27 | The Upjohn Company | (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters |
| GB8609630D0 (en) * | 1986-04-19 | 1986-05-21 | Pfizer Ltd | Anti-arrhythmia agents |
| AU692439B2 (en) * | 1993-03-29 | 1998-06-11 | Zeneca Limited | Heterocyclic compounds as platelet aggregation inhibitors |
| PT825184E (pt) * | 1993-03-29 | 2001-11-30 | Astrazeneca Ab | Derivados heterociclicos como inibidores de agregacao de plaquetas |
-
1996
- 1996-05-28 ES ES009750006A patent/ES2137886B1/es not_active Expired - Fee Related
- 1996-05-28 JP JP8536281A patent/JP2885941B2/ja not_active Expired - Fee Related
- 1996-05-28 MX MX9700379A patent/MX9700379A/es unknown
- 1996-05-28 PL PL96318440A patent/PL318440A1/xx unknown
- 1996-05-28 AU AU58272/96A patent/AU710105B2/en not_active Ceased
- 1996-05-28 CH CH00224/97A patent/CH691808A5/de not_active IP Right Cessation
- 1996-05-28 TR TR97/00020T patent/TR199700020T1/xx unknown
- 1996-05-28 AT AT0900596A patent/AT406675B/de active
- 1996-05-28 DE DE19680509T patent/DE19680509T1/de not_active Withdrawn
- 1996-05-28 KR KR1019970700532A patent/KR100245957B1/ko not_active IP Right Cessation
- 1996-05-28 BR BR9606409A patent/BR9606409A/pt not_active Application Discontinuation
- 1996-05-28 CZ CZ97269A patent/CZ26997A3/cs unknown
- 1996-05-28 HU HU9700274A patent/HUP9700274A3/hu unknown
- 1996-05-28 WO PCT/GB1996/001260 patent/WO1996038416A1/en not_active IP Right Cessation
- 1996-05-28 CA CA002194397A patent/CA2194397A1/en not_active Abandoned
- 1996-05-28 GR GR960100176A patent/GR1002702B/el not_active IP Right Cessation
- 1996-05-28 SK SK130-97A patent/SK13097A3/sk unknown
- 1996-05-28 GB GB9627127A patent/GB2304340B/en not_active Expired - Fee Related
- 1996-05-28 EP EP96919906A patent/EP0796247A1/en not_active Withdrawn
- 1996-05-28 NZ NZ308597A patent/NZ308597A/en unknown
- 1996-05-29 MC MC2347A patent/MC2418A1/xx unknown
- 1996-05-30 IL IL11847796A patent/IL118477A0/xx unknown
- 1996-05-31 NL NL1003243A patent/NL1003243C2/xx not_active IP Right Cessation
- 1996-05-31 IE IE960405A patent/IE960405A1/en not_active IP Right Cessation
- 1996-05-31 BE BE9600491A patent/BE1009520A5/fr not_active IP Right Cessation
- 1996-05-31 IT IT96MI001113A patent/IT1290839B1/it active IP Right Grant
-
1997
- 1997-01-22 LU LU90008A patent/LU90008B1/fr active
- 1997-01-24 SE SE9700203A patent/SE510812C2/sv not_active IP Right Cessation
- 1997-01-30 FI FI970393A patent/FI970393L/sv unknown
- 1997-01-30 DK DK010697A patent/DK10697A/da not_active Application Discontinuation
- 1997-01-31 NO NO970437A patent/NO307460B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI973828A0 (sv) | Föreningar och sammansättningar för tillförsel av aktiva ämnen | |
| FI954963L (sv) | Poly-1-n-alkenaminer och dessa innehållande bränsle- och smörjmedelskompositioner | |
| FI946058L (sv) | Galenisk sammansättning för lokal användning | |
| FI972387L (sv) | Dermalt applicerbara parasiticidkompositioner | |
| BR9611377A (pt) | Inibidor de trombina de ligação não lenta processo para preparar o mesmo composição farmacêutica e uso do inibidor de trombina | |
| KR950704251A (ko) | 프롤릴 엔도펩티다아제 억제 활성을 갖는 화합물 및 그 약학적 용도(compound with prolyl endopeptdase inhibitor activity and pharmaceutical use thereof) | |
| CO5060502A1 (es) | Mezclas insecticidas sinergicas que comprenden espinosad y un cloronicotinilo | |
| MX173582B (es) | Espesante de arcilla para emplear en sistemas basados en agua y compuestos de union que contienen esas composiciones | |
| ID25752A (id) | Senyawa-senyawa piretroid dan komposisi untuk mengontrol hama yang mengandung senyawa-senyawa tersebut | |
| BR9510378A (pt) | Novos agentes sinérgicos par combater insetos e ácaros | |
| BR9306934A (pt) | Composição catalisadora para uso em carbonilação | |
| KR950703855A (ko) | 곤충 및 응애류 방제용 상승작용성 제제(synergistic agents for controlling insects and mites) | |
| FI951009A0 (sv) | Diarylpiperazinoacetamidföreningar användbara som antimuskarinmedel | |
| BR9811458A (pt) | "sistema solvente para penetração melhorada de compostos farmacêuticos" | |
| DE69520056D1 (de) | Verbindungen zur Hemmung von Thrombin | |
| PT101179A (pt) | Composicoes desodorizantes que contem materiais para inibir a aderencia bacteriana, seu metedo de utilizacao e metodo para a determinacao de materiais que inibem a aderencia bacteriana | |
| BR9609695A (pt) | Composição herbicida sinérgica e processo para seu uso | |
| BR9606409A (pt) | Composto opticamente ativo composição farmacêutica processos para inibir agregação de plaqueta em um animal de sangue quente ligação de fibrinogênio a gpiib/iia em um animal de sangue quente e eventos trombóticos que acompanham agnina instável em animal de sangue quente e uso do composto opticamante ativo | |
| FI961716L (sv) | Ibuprofen och flurbiprofen som klådlindrande medel | |
| GT199700054A (es) | Pesticidas que contienen alcaloides de benzofenantridina | |
| EP0867168A3 (de) | Topische Zubereitungen mit oxidationsempfindlichen Wirkstoffen | |
| MX14512A (es) | Composicion fotopolimerizable y articulo que comprende la composicion. | |
| BR9602237A (pt) | Compostos processo para sua preparação agentes pesticidas uso processos para combater pestes e para a preparação e composição | |
| ID22603A (id) | Senyawa piretroid dan komposisi yang mengandung senyawa untuk mengendalikan hama | |
| FI950194L (sv) | Tvåkomponentsfibrinlimkomposition för befrämjning av provrörsbefruktning |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EG | Technical examination (opinion): publication of technical examination (opinion) | ||
| FC | Decision: refusal |